July 7, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Today would have been the day for the Federal Trade Commission to issue a decision on the Walgreens-Rite Aid merger, had Walgreens Boots Alliance and Rite Aid Corp. not elected to scuttle the deal and unveil a downsized transaction eight days ago. Both companies said that, based on signals from the FTC, they thought WBA’s
July 6, 2017 by Chain Drug Review
Fred's, Fred's Pharmacy, Michael Bloom, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Pharmacy reported decreased revenue and same-store sales for June but noted positive results in its pharmacy business. Fred’s said Thursday that for the five weeks ended July 1, sales totaled $197.5 million, down 5.3% from $208.5 million a year earlier. The company attributed the decline the closing of 39 underperforming stores
June 30, 2017 by Chain Drug Review
Fred's, Rite Aid, video, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
Videos
Twenty months ago, Walgreens Boots Alliance announced a $17.2 billion deal to acquire Rite Aid Corp. On Thursday, in the wake of a protracted antitrust review by the Federal Trade Commission, the two companies opted to call of the Walgreens-Rite Aid merger and struck a new agreement. Under the new deal, WBA is slated to
June 13, 2017 by Chain Drug Review
Federal Trade Commission, Fred's, Fred's Pharmacy, Rite Aid, Walgreens, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Pharmacy has procured $550 million in additional funding for its deal to buy up to 1,200 Rite Aid stores in connection with the Walgreens-Rite Aid merger. In an 8-K filing with the Securities and Exchange Commission yesterday, Fred’s said that for a second time it has amended and restated a commitment
June 9, 2017 by Chain Drug Review
Capital Forum, Federal Trade Commission, Fred's, John Standley, Ken Martindale, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Leading Headlines, Retail News
NEW YORK — The Federal Trade Commission is readying a lawsuit to block the Walgreens-Rite Aid merger deal, according to published reports. Citing policy news service Capital Forum, which analyzes the antitrust review of mergers and acquisitions, Investors Business Daily said on Friday that the FTC was “preparing advice” to take action against the transaction,
June 7, 2017 by Chain Drug Review
Fred's, John Standley, Ken Martindale, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — In a memo to employees this week, Rite Aid Corp.’s top executives appear to acknowledge that the company’s acquisition by Walgreens Boots Alliance (WBA) may not be cleared by the Federal Trade Commission. “We remain actively engaged in discussions with the FTC to attempt to gain regulatory approval, and there can be
June 6, 2017 by Chain Drug Review
Fred's Pharmacy, Michael Bloom, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Pharmacy posted a fiscal 2017 first-quarter net loss, stemming largely from charges related to store closings and its planned purchase of at least 865 Rite Aid stores. Fred’s said Tuesday that for the first quarter ended April 29, the company had a net loss of $36.5 million, or 98 cents per
June 5, 2017 by Geoff Walden and Chain Drug Review
Federal Trade Commission, Fred's, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 06-05-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has taken action to force the hand of federal regulators deciding whether to approve its pending acquisition of Rite Aid Corp. WBA and Rite Aid last month notified the Federal Trade Commission that they have complied with the agency’s second request for information on the deal. While
June 1, 2017 by Chain Drug Review
Brian Tanquilut, Fred's Pharmacy, Michael Bloom, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Pharmacy saw same-store sales edge up in May, though store closings led to a year-over-year revenue decline for the month. Fred’s said Thursday that sales for the four weeks ended May 27 totaled $160.1 million, down 3.1% from $165.2 million a year earlier. The company attributed the sales decrease to the closure
May 16, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog, Leading Headlines
Walgreens Boots Alliance and Rite Aid last week said they’ve complied with the Federal Trade Commission’s second request for information on their merger deal. But it appears the FTC still wants to know more. The New York Post reported Tuesday that the FTC has issued civil investigative demands (CIDs) to Walgreens vendors and competitors to
May 9, 2017 by Chain Drug Review
John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill., and CAMP HILL, Pa. — Walgreens Boots Alliance (WBA) and Rite Aid Corp. said they have met the Federal Trade Commission’s second request for information on their planned merger. Late Monday, WBA and Rite Aid announced that they have “certified substantial compliance,” meaning that they have provided the information needed to determine if
May 4, 2017 by Chain Drug Review
Fred's, Fred's Pharmacy, Michael Bloom, Rite Aid, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Pharmacy
MEMPHIS, Tenn. — Fred’s Pharmacy reported declined sales for April and its fiscal 2017 first quarter, though seasonal business lifted same-store sales for the month. Fred’s said Thursday that sales for the four weeks ended April 29 totaled $159.1 million, down 3% from $163.9 million a year earlier. April same-store sales edged up 1.2% year
April 26, 2017 by CDR Blog and Chain Drug Review
Albertsons, Amazon, Cerberus Capital Management, JANA Partners, Scott Mushkin, Sprouts Farmers Markets, Walgreens-Rite Aid merger, Whole Foods Markets, Wolfe Research
CDR Blog
Albertsons Cos. reportedly is eyeing Whole Foods Markets, but it appears such an acquisition would be difficult for the Boise-based food and drug retailer to swallow. The Financial Times reported this week that Cerberus Capital Management, which leads the investor group that owns Albertsons, has engaged in preliminary discussions with bankers about a possible bid
April 25, 2017 by Chain Drug Review
EnvisionRx, John Standley, RediClinic, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Despite declines in net income, Rite Aid Corp. posted increased sales and exceeded Wall Street’s adjusted earnings per share forecast for its fiscal 2017 fourth quarter and year. Chairman and chief executive officer John Standley, however, noted that the ongoing regulatory review of Rite Aid’s deal to be acquired by Walgreens